Breast Cancer Research

The decline in mortality rates among breast cancerof breast cancer also high. However, even if one
patients can be credited to breast cancer research.inherits a bad gene, one gene is sufficient to do its
While advocates would argue that it is earlytask, which is to control cell growth. It is therefore
detection and breast cancer awareness that haveimportant to take care of this gene. If both genes
saved more lives, it cannot be denied also thatare damaged, cell growth cannot be controlled
research also made a contribution in this undertaking.anymore. This being so, the abnormal, uncontrollable
With the millions of dollars spent on research, it iscell growth results in cancer cells. Recent studies now
only logical for research to generate more discoveriesshow that aside from these two genes, there is
and developments.another gene called HMMR that increases breast
Breast cancer research is usually done by agenciescancer risk. A mutation of this gene increases the risk
such as the National Cancer Institute and by breastof breast cancer. Studies show that women with a
cancer associations. The National Cancer Institute hasmutation in this gene have a risk which is 2.7 times
organized a Progress Review Group, composed ofhigher than those without it. It was also seen that
members from different fields such as scientific,this gene interacts with BRCA1 and their interaction
medical, industry and advocacy communities, thatresults in gene alteration, making either gene unstable
convene to discuss research issues. They releaseand paving the way for breast cancer to develop.
recommendations for a research agenda, whichResearch and clinical studies have shown that there
contain research goals in different fields such asare certain workplaces where breast cancer risk
biology, genetics, prevention, treatment, and others.factors may be increased. These are working in a
Breast cancer associations also fund their owntextile industry and in hospital departments where
research and submit whatever recommendations thatradiation may be exposed. While these increase the
they may come up with. What they usually conductrisk, there are also factors that reduce the risk.
are clinical trials, where effects of new treatmentsThese include working in a managerial position and
are studied among those diagnosed with breasteating a high-fiber, low salt diet.
cancer. Organizations also lobby the passage of lawsAnother research was made to determine the
both at the state and national level for the allocationconnection between fat consumption and breast
of more funds for research.cancer risk and researchers found that there was no
One of the more important aspects of breast cancerassociation between fat consumption, whether
research is identifying risk factors. By identifying riskmonounsaturated, polyunsaturated or saturated, and
factors and controlling those which are modifiable, wethe overall risk for breast cancer.
are able to reduce the risk of breast cancerResearchers are still studying the effects of birth
incidence. Treatments are also being developed tocontrol pills to breast cancer risk. While recent studies
control, if not eliminate, the "uncontrollable" riskshowed a slight link, the results are not conclusive
factors. Development of new technology for betteryet.
breast imaging is also being done. With betterBreast cancer research is an important aspect in the
equipment, tumors can be more easily detected,fight against breast cancer. Without it, no new
even for those women who have high breasttreatments are made available, no new risk factors
density.are discovered. That is why it is necessary to fund
Among the developments in breast cancer researchresearch programs of the government and of other
is the discovery of a new gene that can increaseorganizations dedicated to public service. Participate in
breast cancer risk. BRCA1 and BRCA2 are the twofund-raising activities or make donations by
genes that can be linked to breast cancer and thesesupporting causes or purchasing merchandise where a
are genes that we inherit from our parents. That isfraction of the sales is given to fund research. These
why if one parent has had cancer, the risk ofdonations, minimal as they may be, will go a long way
acquiring this defective gene is high, making the riskto help us fight breast cancer.